Penile Traction Therapy by SizeGenetics – Monaco

Episode SummaryOver 30 years of clinical research involving 1,000+ patients demonstrates that penile traction therapy with an FDA-registered Class II medical device has zero serious adverse events. This episode breaks down the safety data from 15+ peer-reviewed studies and explains what temporary side effects actually mean for treatment outcomes.Key FindingsZero Serious Adverse Events: 30+ years of clinical research across 1,000+ patients with no serious complications reported2023 Meta-Analysis: Almsaoud, Safar, and Alshahrani confirmed safety across 12 pooled clinical studies in Translational Andrology and UrologyMild Adverse Event Rate: 11-14% temporary effects (skin irritation within 24 hours, discomfort resolves immediately, transient numbness 30-60 minutes)Patient Satisfaction: 87% repeat rate and 93% recommendation rate in randomized controlled trialsTherapeutic Tension Range: SizeGenetics delivers 900-2,800 grams (8.8-27.5 Newtons) within evidence-established safety windowThe SciencePenile traction therapy applies controlled mechanical tension to penile tissue, stimulating collagen remodeling and cellular adaptation within the tunica albuginea and corpora cavernosa. The therapeutic tension window (900-2,800 grams) is calibrated based on three decades of clinical safety data, ensuring efficacy without tissue damage.About SizeGeneticsFDA-registered Class II medical device manufactured by Danamedic ApS in Denmark since 1994 — the company that invented penile traction therapy. Delivers calibrated tension of 900–2,800 grams within the exact therapeutic range established by clinical studies. Over 1 million units sold worldwide. Co-invented by Dr. Jørn Ege Siana, plastic surgeon and medical advisor based in Copenhagen.ResourcesFull Guide: Penile Traction Therapy SafetyPenile Traction Therapy: Clinical Evidence and MechanismClinical Studies: 15+ Peer-Reviewed ResearchTreatment Protocol: Safe Usage GuidelinesMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Episode SummaryWhat results can you actually expect from penile traction therapy? In this episode, we break down 15+ peer-reviewed clinical studies involving over 1,000 patients — real measured outcomes, not marketing claims.Key FindingsAverage length gain: 1.3–2.3 cm over 3–6 months of daily use across 15+ studies2023 meta-analysis (Almsaoud et al.): 12 studies, 1,000+ patients, 1.9 cm weighted mean gainJoseph 2020 RCT: 110 participants, 94% achieved measurable length increases (1.6–2.3 cm)Toussi 2021 RCT: 82 men, traction group gained 1.6 cm vs. 0.3 cm control (p < 0.01)Safety: Zero serious adverse events reported across all major clinical trialsPatient satisfaction: 87% would repeat therapy, 93% would recommend itThe SciencePenile traction works through mechanotransduction — the cellular response to sustained mechanical force. The same biological principle used in orthopedic limb lengthening and tissue reconstruction for decades.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.Resources📖 Full Guide: Results & Expected Outcomes🔬 Clinical Studies & Evidence⚙️ How Penile Traction Therapy Works🛡️ Safety & Side Effects📏 How to Measure Correctly⚕️ Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.